· AIM:Todescribetheclinicalcharacteristicswith genetic lesions in a Chinese family with Crouzon syndrome.
INTRODUCTION
C rouzonsyndromeisoneofthefibroblastgrowthfactor receptor2(FGFR2)-relatedcraniosynostosissyndromes withanincidenceof1.6in100000births [1] .Eighttypesof disorderscomprisethe -relatedcraniosynostosis syndromes,includingPfeiffersyndrome,Apertsyndrome, Crouzonsyndrome,Beare-Stevensonsyndrome, relatedisolatedcoronalsynostosis,Jackson-Weisssyndrome, Crouzonsyndromewithacanthosisnigricans (AN),and Muenkesyndrome [1] .Clinically,patientswithCrouzon syndromearepresentedwithcraniofacialabnormalities, includingsignificantproptosis,exotropia,andmandibular prognathism,whereastheirintellectandextremitiesareoften normal [2] [3] [4] [5] .Reportedly,nearly30%patientswilldevelop progressivehydrocephalus,oftenwithtonsillarherniation, andsacrococcygealtailhasalsobeendescribed [6] . FamilieswithCrouzonsyndromeusuallydemonstratean autosomaldominantinheritancepattern.Byfay,only mutationsinthe gene(MIM:176943)havebeen foundimplicatedintheetiologyofCrouzonsyndrome [7] [8] [9] .
,locatedon10q26,encodestheFGFR-2protein,a tyrosine-proteinkinaseactingascell-surfacereceptorfor fibroblastgrowthfactors.FGFR-2includesthreeextracellular immunoglobulin(Ig)likeC2-typedomains(Ig-I,Ig-IIand Ig-III),atransmembranedomain,andacytoplasmictyrosine kinasedomains.Todate,nearly60 mutationshave beenreportedincausingCrouzonsyndrome,mostofwhich constructthecrystalstructuresofthewildtypeandmutant FGFR-2aspreviouslydescribed [13] [14] .Predictedstructures weredisplayedwithPyMolsoftware(version1.5). [17] [18] [19] ,butneverintheChinese population.Crystalstructuralmodelingindicatesthatthis mutationwouldleadtoasignificantconformationalchange intheextracellularIg-IIIloopbygeneratingahydrogenbond betweenTrp342andGlu325,andelongatingtwo 茁 sheets. FGFR-2isanessentialproteininvolvesinmultiplesignaling pathways.Ligandbindingwillphosphorylateafewproteins, including1-phosphatidylinositol4,5-bisphosphatephosphodiesterasegamma-1(PLCG1),fibroblastgrowthfactor receptorsubstrate2(FRS2),andserine/threonine-protein kinasePAK4(PAK4),thusresultingintheactivationof corresponding signalingcascades [20] [21] [22] [23] . MostCrouzon syndromecausative mutationwouldleadtoagain orlossofcysteineresidues,whichformthedisulfidebondsin theIg-IIIloop,andregulatethebindingofFGFR-2tothe ligand [1] .Themutationidentifiedinthisstudyisamissense substitutionfromcysteinetotryptophanatresidue342of FGFR-2,whichalsoeliminatesacysteine.Thus,wehighly hypothesizethatthismutationwouldcauseconstitutive kinaseactivationorimpairregularFGFR-2maturation, internalization,ordegradation,therebyresultinginaberrant signaling [24] 
RESULTS

